Contrast Clearance Analysis for Differentiating Tumor From Treatment Effects
Yael Mardor, PhD, from the Chaim Sheba Medical Center in Israel discusses MRI-based treatment response assessment maps for differentiating tumor from treatment effects in patients with brain tumors. She begins by outlining the delayed contract extravasation methodology of the software Elements Contrast Clearance Analysis. She then explains the rationale and histological validation of the methodology before delving into specific case examples and discussed its place as a tool for clinicial decision-making.
Delayed contrast extravasation MRI for depicting tumor and non-tumoral tissues
Targets, tracts, tumors and trouble – Why Brainlab is an essential element for a successful brain radiosurgery program
Expert demo session: Elements Multiple Brain Mets SRS 3.0
Novalis Circle technical webinar: Elements Multiple Brain Mets SRS
Multiple Brain Metastases SRS for small targets – simple case
Trajectory Based Treatment Planning and Delivery for Cranial Radiosurgery
Reporting Clinical Outcomes via the NeuroPoint Alliance National...
Advanced MR and PET Imaging: Is it Really Useful in Brain Tumor Radiosurgery?
Interested in watching this clinical talk? Please click on the button “WATCH Video” to enter your contact details and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Video related updates.WATCH Video
Thank you for watching! Please enter your contact details below to continue watching and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Circle video related updates.Watch video No Thanks
Already Novalis Circle Member?Member Login